One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for...
NIAID
Colorized scanning electron micrograph of a cell (purple) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample....
An adjuvant developed with funding from the National Institutes of Health has contributed to the success of the highly efficacious...
More than a century has passed since the March 24, 1882, announcement by Robert Koch that Mycobacterium tuberculosis (Mtb) bacteria cause tuberculosis...
A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers....
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well...
Study identifies potential approach to treat severe respiratory distress in patients with COVID-19 Early data from a clinical study suggest...
